1.15
Integra LifeSciences Holdings Corporation
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
1.16
FY23:
1.06
FY24:
1.08
FY25:
1.16
(positive)
Change from FY21 to FY25
billions USD
FY21:
2.63
FY22:
2.73
FY23:
2.72
FY24:
2.96
FY25:
2.44
Total assets
Change from FY21 to FY25
billions USD
FY21:
3.78
FY22:
3.89
FY23:
3.78
FY24:
4.04
FY25:
3.60
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.34
FY22:
0.32
FY23:
0.31
FY24:
0.92
FY25:
0.46
(negative)
Change from FY21 to FY25
billions USD
FY21:
1.76
FY22:
1.76
FY23:
1.89
FY24:
1.57
FY25:
2.10
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.68
FY22:
1.80
FY23:
1.59
FY24:
1.55
FY25:
1.04
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
3.78
FY22:
3.89
FY23:
3.78
FY24:
4.04
FY25:
3.60
All amounts in billions USD